Lv4
522 积分 2023-11-10 加入
Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia
2天前
已完结
Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol
3天前
已完结
Triglyceride-Rich Lipoproteins, Remnants, and Atherosclerotic Cardiovascular Disease Risk
3天前
已完结
Residual cardiovascular risk: When should we treat it?
4天前
已完结
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table
4天前
已完结
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease
7天前
已完结
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases
8天前
已完结
Author Correction: Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease
8天前
已完结
Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study
9天前
已完结
The Emerging Potential of Apolipoprotein C-III Inhibition for ASCVD Prevention: A State-of-the-Art Review
9天前
已完结
皖公网安备34019202002308
